In March 2022 at the APhA Annual Meeting & Exposition in San Antonio, the APhA–ASP House of Delegates passed adopted New Business Item (NBI) 2022.1: Gender Expansive Rights, Education, and Advocacy. Within this adopted NBI, APhA–ASP encourages the improvement in care for gender-expansive patients by integrating gender-affirming therapy (GAT) into pharmacy school curriculum and supports the use of GAT in transgender and nonbinary (TNB) patients with an informed consent model.